nodes	percent_of_prediction	percent_of_DWPC	metapath
Drospirenone—Eplerenone—hypertension	0.172	0.535	CrCtD
Drospirenone—Spironolactone—hypertension	0.15	0.465	CrCtD
Drospirenone—NR3C2—hypertension	0.123	0.619	CbGaD
Drospirenone—AR—hypertension	0.0546	0.275	CbGaD
Drospirenone—NR3C2—Eplerenone—hypertension	0.045	0.235	CbGbCtD
Drospirenone—NR3C2—Spironolactone—hypertension	0.0353	0.184	CbGbCtD
Drospirenone—NR3C2—Felodipine—hypertension	0.0347	0.181	CbGbCtD
Drospirenone—PGR—Spironolactone—hypertension	0.0228	0.119	CbGbCtD
Drospirenone—PTGS2—hypertension	0.021	0.106	CbGaD
Drospirenone—AR—Spironolactone—hypertension	0.0183	0.0956	CbGbCtD
Drospirenone—Eplerenone—Spironolactone—hypertension	0.0168	0.0908	CrCrCtD
Drospirenone—BCHE—Perindopril—hypertension	0.0147	0.0765	CbGbCtD
Drospirenone—Spironolactone—Eplerenone—hypertension	0.0146	0.079	CrCrCtD
Drospirenone—Potassium Canrenoate—Spironolactone—hypertension	0.0127	0.0687	CrCrCtD
Drospirenone—BCHE—Ramipril—hypertension	0.0121	0.0634	CbGbCtD
Drospirenone—Medroxyprogesterone Acetate—Eplerenone—hypertension	0.0119	0.0643	CrCrCtD
Drospirenone—Megestrol acetate—Spironolactone—hypertension	0.0116	0.0629	CrCrCtD
Drospirenone—Cortisone acetate—Eplerenone—hypertension	0.0104	0.0562	CrCrCtD
Drospirenone—Medroxyprogesterone Acetate—Spironolactone—hypertension	0.0104	0.0559	CrCrCtD
Drospirenone—Cortisone acetate—Spironolactone—hypertension	0.00906	0.0489	CrCrCtD
Drospirenone—Progesterone—Eplerenone—hypertension	0.00904	0.0489	CrCrCtD
Drospirenone—Testosterone Propionate—Eplerenone—hypertension	0.00904	0.0489	CrCrCtD
Drospirenone—Methyltestosterone—Eplerenone—hypertension	0.00882	0.0476	CrCrCtD
Drospirenone—Testolactone—Spironolactone—hypertension	0.00879	0.0475	CrCrCtD
Drospirenone—PTGS2—Bumetanide—hypertension	0.00873	0.0455	CbGbCtD
Drospirenone—Progesterone—Spironolactone—hypertension	0.00787	0.0425	CrCrCtD
Drospirenone—Testosterone Propionate—Spironolactone—hypertension	0.00787	0.0425	CrCrCtD
Drospirenone—Testosterone—Eplerenone—hypertension	0.00785	0.0424	CrCrCtD
Drospirenone—Methyltestosterone—Spironolactone—hypertension	0.00767	0.0414	CrCrCtD
Drospirenone—Hydrocortisone—Eplerenone—hypertension	0.00738	0.0398	CrCrCtD
Drospirenone—Testosterone—Spironolactone—hypertension	0.00683	0.0369	CrCrCtD
Drospirenone—Hydrocortisone—Spironolactone—hypertension	0.00642	0.0347	CrCrCtD
Drospirenone—NR3C2—collecting duct of renal tubule—hypertension	0.00301	0.16	CbGeAlD
Drospirenone—NR3C2—nephron—hypertension	0.00134	0.0712	CbGeAlD
Drospirenone—PGR—artery—hypertension	0.000695	0.0369	CbGeAlD
Drospirenone—PTGS2—nephron—hypertension	0.000622	0.033	CbGeAlD
Drospirenone—PTGS2—hindlimb—hypertension	0.000566	0.0301	CbGeAlD
Drospirenone—PGR—blood vessel—hypertension	0.000542	0.0288	CbGeAlD
Drospirenone—NR3C2—cardiac ventricle—hypertension	0.00042	0.0223	CbGeAlD
Drospirenone—NR3C2—myocardium—hypertension	0.000395	0.021	CbGeAlD
Drospirenone—PGR—myocardium—hypertension	0.000367	0.0195	CbGeAlD
Drospirenone—PTGS2—artery—hypertension	0.000347	0.0184	CbGeAlD
Drospirenone—NR3C2—brainstem—hypertension	0.000318	0.0169	CbGeAlD
Drospirenone—AR—cardiac ventricle—hypertension	0.000311	0.0165	CbGeAlD
Drospirenone—PTGS2—endothelium—hypertension	0.000293	0.0156	CbGeAlD
Drospirenone—AR—myocardium—hypertension	0.000292	0.0155	CbGeAlD
Drospirenone—NR3C2—nephron tubule—hypertension	0.000289	0.0154	CbGeAlD
Drospirenone—NR3C2—adrenal cortex—hypertension	0.000285	0.0151	CbGeAlD
Drospirenone—NR3C2—heart—hypertension	0.000275	0.0146	CbGeAlD
Drospirenone—NR3C2—smooth muscle tissue—hypertension	0.000273	0.0145	CbGeAlD
Drospirenone—PTGS2—blood vessel—hypertension	0.00027	0.0144	CbGeAlD
Drospirenone—NR3C2—cardiovascular system—hypertension	0.00026	0.0138	CbGeAlD
Drospirenone—PGR—heart—hypertension	0.000256	0.0136	CbGeAlD
Drospirenone—NR3C2—kidney—hypertension	0.000254	0.0135	CbGeAlD
Drospirenone—PGR—smooth muscle tissue—hypertension	0.000254	0.0135	CbGeAlD
Drospirenone—BCHE—cardiac ventricle—hypertension	0.000253	0.0134	CbGeAlD
Drospirenone—PGR—decidua—hypertension	0.000249	0.0132	CbGeAlD
Drospirenone—NR3C2—cortex of kidney—hypertension	0.000248	0.0131	CbGeAlD
Drospirenone—PGR—cardiovascular system—hypertension	0.000242	0.0128	CbGeAlD
Drospirenone—NR3C2—cardiac atrium—hypertension	0.000236	0.0125	CbGeAlD
Drospirenone—NR3C2—medulla oblongata—hypertension	0.000222	0.0118	CbGeAlD
Drospirenone—AR—adrenal cortex—hypertension	0.000211	0.0112	CbGeAlD
Drospirenone—NR3C2—adrenal gland—hypertension	0.000206	0.0109	CbGeAlD
Drospirenone—AR—heart—hypertension	0.000204	0.0108	CbGeAlD
Drospirenone—AR—smooth muscle tissue—hypertension	0.000202	0.0107	CbGeAlD
Drospirenone—AR—decidua—hypertension	0.000198	0.0105	CbGeAlD
Drospirenone—AR—cardiovascular system—hypertension	0.000192	0.0102	CbGeAlD
Drospirenone—BCHE—brainstem—hypertension	0.000192	0.0102	CbGeAlD
Drospirenone—PGR—adrenal gland—hypertension	0.000191	0.0101	CbGeAlD
Drospirenone—AR—kidney—hypertension	0.000188	0.01	CbGeAlD
Drospirenone—AR—cortex of kidney—hypertension	0.000183	0.00974	CbGeAlD
Drospirenone—NR3C2—endocrine gland—hypertension	0.000178	0.00947	CbGeAlD
Drospirenone—AR—cardiac atrium—hypertension	0.000174	0.00926	CbGeAlD
Drospirenone—BCHE—nephron tubule—hypertension	0.000174	0.00926	CbGeAlD
Drospirenone—BCHE—heart—hypertension	0.000166	0.00881	CbGeAlD
Drospirenone—PGR—endocrine gland—hypertension	0.000166	0.0088	CbGeAlD
Drospirenone—Eplerenone—CYP11B2—hypertension	0.000165	0.086	CrCbGaD
Drospirenone—BCHE—smooth muscle tissue—hypertension	0.000165	0.00874	CbGeAlD
Drospirenone—NR3C2—central nervous system—hypertension	0.000161	0.00853	CbGeAlD
Drospirenone—BCHE—cardiovascular system—hypertension	0.000157	0.00831	CbGeAlD
Drospirenone—AR—adrenal gland—hypertension	0.000152	0.00808	CbGeAlD
Drospirenone—PGR—central nervous system—hypertension	0.000149	0.00793	CbGeAlD
Drospirenone—BCHE—cardiac atrium—hypertension	0.000142	0.00754	CbGeAlD
Drospirenone—BCHE—medulla oblongata—hypertension	0.000134	0.0071	CbGeAlD
Drospirenone—PTGS2—adrenal cortex—hypertension	0.000132	0.00702	CbGeAlD
Drospirenone—Medroxyprogesterone Acetate—HSD3B2—hypertension	0.000132	0.0688	CrCbGaD
Drospirenone—AR—endocrine gland—hypertension	0.000132	0.00701	CbGeAlD
Drospirenone—PTGS2—heart—hypertension	0.000128	0.00679	CbGeAlD
Drospirenone—PTGS2—smooth muscle tissue—hypertension	0.000127	0.00674	CbGeAlD
Drospirenone—BCHE—adrenal gland—hypertension	0.000124	0.00658	CbGeAlD
Drospirenone—PTGS2—cardiovascular system—hypertension	0.000121	0.00641	CbGeAlD
Drospirenone—Spironolactone—CYP11B1—hypertension	0.00012	0.0625	CrCbGaD
Drospirenone—AR—central nervous system—hypertension	0.000119	0.00632	CbGeAlD
Drospirenone—PTGS2—kidney—hypertension	0.000118	0.00627	CbGeAlD
Drospirenone—Eplerenone—NR3C2—hypertension	0.000117	0.0611	CrCbGaD
Drospirenone—Spironolactone—CYP11B2—hypertension	0.000113	0.0587	CrCbGaD
Drospirenone—BCHE—endocrine gland—hypertension	0.000107	0.0057	CbGeAlD
Drospirenone—PTGS2—medulla oblongata—hypertension	0.000103	0.00547	CbGeAlD
Drospirenone—BCHE—central nervous system—hypertension	9.68e-05	0.00514	CbGeAlD
Drospirenone—PTGS2—adrenal gland—hypertension	9.54e-05	0.00507	CbGeAlD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Esmolol—hypertension	9.1e-05	0.0019	CcSEcCtD
Drospirenone—Erythema multiforme—Propranolol—hypertension	9.04e-05	0.00189	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Bepridil—hypertension	9.04e-05	0.00189	CcSEcCtD
Drospirenone—Haemoglobin—Fosinopril—hypertension	9e-05	0.00188	CcSEcCtD
Drospirenone—Nervous system disorder—Isradipine—hypertension	8.99e-05	0.00187	CcSEcCtD
Drospirenone—Haemorrhage—Fosinopril—hypertension	8.96e-05	0.00187	CcSEcCtD
Drospirenone—Skin disorder—Isradipine—hypertension	8.9e-05	0.00186	CcSEcCtD
Drospirenone—Haemoglobin—Nifedipine—hypertension	8.88e-05	0.00185	CcSEcCtD
Drospirenone—Breast disorder—Betaxolol—hypertension	8.88e-05	0.00185	CcSEcCtD
Drospirenone—Haemorrhage—Nifedipine—hypertension	8.84e-05	0.00184	CcSEcCtD
Drospirenone—Erythema multiforme—Indapamide—hypertension	8.75e-05	0.00183	CcSEcCtD
Drospirenone—Erythema multiforme—Diltiazem—hypertension	8.75e-05	0.00183	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Acebutolol—hypertension	8.75e-05	0.00182	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Candesartan—hypertension	8.73e-05	0.00182	CcSEcCtD
Drospirenone—Depression—Clonidine—hypertension	8.67e-05	0.00181	CcSEcCtD
Drospirenone—Erythema multiforme—Carvedilol—hypertension	8.67e-05	0.00181	CcSEcCtD
Drospirenone—Breast disorder—Losartan—hypertension	8.65e-05	0.0018	CcSEcCtD
Drospirenone—Nervous system disorder—Esmolol—hypertension	8.61e-05	0.0018	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Methyldopa—hypertension	8.6e-05	0.00179	CcSEcCtD
Drospirenone—Nausea—Bendroflumethiazide—hypertension	8.58e-05	0.00179	CcSEcCtD
Drospirenone—Skin disorder—Esmolol—hypertension	8.53e-05	0.00178	CcSEcCtD
Drospirenone—Erythema multiforme—Fosinopril—hypertension	8.47e-05	0.00177	CcSEcCtD
Drospirenone—Depression—Trandolapril—hypertension	8.46e-05	0.00176	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Amiloride—hypertension	8.45e-05	0.00176	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Hydralazine—hypertension	8.45e-05	0.00176	CcSEcCtD
Drospirenone—Depression—Enalapril—hypertension	8.42e-05	0.00176	CcSEcCtD
Drospirenone—Angiopathy—Diltiazem—hypertension	8.4e-05	0.00175	CcSEcCtD
Drospirenone—Mental disorder—Propranolol—hypertension	8.38e-05	0.00175	CcSEcCtD
Drospirenone—Cerebrovascular accident—Ramipril—hypertension	8.38e-05	0.00175	CcSEcCtD
Drospirenone—Acute coronary syndrome—Trandolapril—hypertension	8.36e-05	0.00174	CcSEcCtD
Drospirenone—Erythema multiforme—Nifedipine—hypertension	8.35e-05	0.00174	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Pindolol—hypertension	8.34e-05	0.00174	CcSEcCtD
Drospirenone—Acute coronary syndrome—Enalapril—hypertension	8.33e-05	0.00174	CcSEcCtD
Drospirenone—Erythema multiforme—Verapamil—hypertension	8.32e-05	0.00173	CcSEcCtD
Drospirenone—Angiopathy—Carvedilol—hypertension	8.32e-05	0.00173	CcSEcCtD
Drospirenone—Myocardial infarction—Trandolapril—hypertension	8.31e-05	0.00173	CcSEcCtD
Drospirenone—Depression—Telmisartan—hypertension	8.31e-05	0.00173	CcSEcCtD
Drospirenone—Nervous system disorder—Acebutolol—hypertension	8.28e-05	0.00173	CcSEcCtD
Drospirenone—Myocardial infarction—Enalapril—hypertension	8.28e-05	0.00173	CcSEcCtD
Drospirenone—PTGS2—endocrine gland—hypertension	8.28e-05	0.00439	CbGeAlD
Drospirenone—Haemoglobin—Valsartan—hypertension	8.23e-05	0.00172	CcSEcCtD
Drospirenone—Acute coronary syndrome—Telmisartan—hypertension	8.21e-05	0.00171	CcSEcCtD
Drospirenone—Skin disorder—Acebutolol—hypertension	8.2e-05	0.00171	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Quinapril—hypertension	8.2e-05	0.00171	CcSEcCtD
Drospirenone—Cerebrovascular accident—Timolol—hypertension	8.19e-05	0.00171	CcSEcCtD
Drospirenone—Haemorrhage—Valsartan—hypertension	8.19e-05	0.00171	CcSEcCtD
Drospirenone—Myocardial infarction—Telmisartan—hypertension	8.17e-05	0.0017	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Amlodipine—hypertension	8.16e-05	0.0017	CcSEcCtD
Drospirenone—Angiopathy—Eplerenone—hypertension	8.08e-05	0.00168	CcSEcCtD
Drospirenone—Nausea—Hydroflumethiazide—hypertension	8.04e-05	0.00168	CcSEcCtD
Drospirenone—Angiopathy—Nifedipine—hypertension	8.02e-05	0.00167	CcSEcCtD
Drospirenone—Spironolactone—NR3C2—hypertension	8e-05	0.0417	CrCbGaD
Drospirenone—Hydrocortisone—CYP11B1—hypertension	7.97e-05	0.0415	CrCbGaD
Drospirenone—Mental disorder—Doxazosin—hypertension	7.94e-05	0.00166	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Isradipine—hypertension	7.91e-05	0.00165	CcSEcCtD
Drospirenone—Affect lability—Timolol—hypertension	7.9e-05	0.00165	CcSEcCtD
Drospirenone—Nausea—Reserpine—hypertension	7.81e-05	0.00163	CcSEcCtD
Drospirenone—Nausea—Ethacrynic acid—hypertension	7.81e-05	0.00163	CcSEcCtD
Drospirenone—Mental disorder—Eplerenone—hypertension	7.8e-05	0.00163	CcSEcCtD
Drospirenone—Acute coronary syndrome—Perindopril—hypertension	7.76e-05	0.00162	CcSEcCtD
Drospirenone—Mental disorder—Nifedipine—hypertension	7.74e-05	0.00161	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Spironolactone—hypertension	7.74e-05	0.00161	CcSEcCtD
Drospirenone—Acute coronary syndrome—Irbesartan—hypertension	7.73e-05	0.00161	CcSEcCtD
Drospirenone—Nervous system disorder—Amlodipine—hypertension	7.72e-05	0.00161	CcSEcCtD
Drospirenone—Myocardial infarction—Perindopril—hypertension	7.71e-05	0.00161	CcSEcCtD
Drospirenone—Myocardial infarction—Irbesartan—hypertension	7.69e-05	0.0016	CcSEcCtD
Drospirenone—Acute coronary syndrome—Hydrochlorothiazide—hypertension	7.67e-05	0.0016	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Metoprolol—hypertension	7.67e-05	0.0016	CcSEcCtD
Drospirenone—Skin disorder—Amlodipine—hypertension	7.65e-05	0.00159	CcSEcCtD
Drospirenone—Myocardial infarction—Hydrochlorothiazide—hypertension	7.62e-05	0.00159	CcSEcCtD
Drospirenone—Mood swings—Timolol—hypertension	7.6e-05	0.00159	CcSEcCtD
Drospirenone—Cerebrovascular accident—Lisinopril—hypertension	7.6e-05	0.00158	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Esmolol—hypertension	7.58e-05	0.00158	CcSEcCtD
Drospirenone—Depression—Betaxolol—hypertension	7.55e-05	0.00157	CcSEcCtD
Drospirenone—Nausea—Fenoldopam—hypertension	7.54e-05	0.00157	CcSEcCtD
Drospirenone—Hydrocortisone—CYP11B2—hypertension	7.49e-05	0.039	CrCbGaD
Drospirenone—Acute coronary syndrome—Betaxolol—hypertension	7.46e-05	0.00156	CcSEcCtD
Drospirenone—PTGS2—central nervous system—hypertension	7.46e-05	0.00396	CbGeAlD
Drospirenone—Angiopathy—Valsartan—hypertension	7.43e-05	0.00155	CcSEcCtD
Drospirenone—Myocardial infarction—Betaxolol—hypertension	7.42e-05	0.00155	CcSEcCtD
Drospirenone—Breast disorder—Ramipril—hypertension	7.42e-05	0.00155	CcSEcCtD
Drospirenone—Angiopathy—Olmesartan—hypertension	7.4e-05	0.00154	CcSEcCtD
Drospirenone—Nausea—Nebivolol—hypertension	7.35e-05	0.00153	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Acebutolol—hypertension	7.29e-05	0.00152	CcSEcCtD
Drospirenone—Nervous system disorder—Metoprolol—hypertension	7.26e-05	0.00151	CcSEcCtD
Drospirenone—Nervous system disorder—Guanabenz—hypertension	7.26e-05	0.00151	CcSEcCtD
Drospirenone—Breast disorder—Timolol—hypertension	7.25e-05	0.00151	CcSEcCtD
Drospirenone—Erythema multiforme—Trandolapril—hypertension	7.2e-05	0.0015	CcSEcCtD
Drospirenone—Skin disorder—Metoprolol—hypertension	7.19e-05	0.0015	CcSEcCtD
Drospirenone—Skin disorder—Guanabenz—hypertension	7.19e-05	0.0015	CcSEcCtD
Drospirenone—Mental disorder—Valsartan—hypertension	7.18e-05	0.0015	CcSEcCtD
Drospirenone—Erythema multiforme—Enalapril—hypertension	7.17e-05	0.0015	CcSEcCtD
Drospirenone—Mental disorder—Olmesartan—hypertension	7.14e-05	0.00149	CcSEcCtD
Drospirenone—Haemoglobin—Perindopril—hypertension	7.1e-05	0.00148	CcSEcCtD
Drospirenone—Angiopathy—Clonidine—hypertension	7.08e-05	0.00148	CcSEcCtD
Drospirenone—Haemorrhage—Perindopril—hypertension	7.06e-05	0.00147	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Propranolol—hypertension	7.04e-05	0.00147	CcSEcCtD
Drospirenone—Nausea—Torasemide—hypertension	6.93e-05	0.00145	CcSEcCtD
Drospirenone—Angiopathy—Trandolapril—hypertension	6.91e-05	0.00144	CcSEcCtD
Drospirenone—Testosterone Propionate—CYP17A1—hypertension	6.9e-05	0.036	CrCbGaD
Drospirenone—Erythema multiforme—Captopril—hypertension	6.88e-05	0.00143	CcSEcCtD
Drospirenone—Mental disorder—Clonidine—hypertension	6.84e-05	0.00143	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Indapamide—hypertension	6.81e-05	0.00142	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Amlodipine—hypertension	6.8e-05	0.00142	CcSEcCtD
Drospirenone—Angiopathy—Telmisartan—hypertension	6.79e-05	0.00142	CcSEcCtD
Drospirenone—Hydrocortisone—ANXA1—hypertension	6.77e-05	0.0353	CrCbGaD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Carvedilol—hypertension	6.75e-05	0.00141	CcSEcCtD
Drospirenone—Nausea—Chlorothiazide—hypertension	6.75e-05	0.00141	CcSEcCtD
Drospirenone—Breast disorder—Lisinopril—hypertension	6.73e-05	0.0014	CcSEcCtD
Drospirenone—Erythema multiforme—Perindopril—hypertension	6.68e-05	0.00139	CcSEcCtD
Drospirenone—Mental disorder—Trandolapril—hypertension	6.67e-05	0.00139	CcSEcCtD
Drospirenone—Nervous system disorder—Propranolol—hypertension	6.66e-05	0.00139	CcSEcCtD
Drospirenone—Nausea—Chlorthalidone—hypertension	6.62e-05	0.00138	CcSEcCtD
Drospirenone—Erythema multiforme—Hydrochlorothiazide—hypertension	6.6e-05	0.00138	CcSEcCtD
Drospirenone—Skin disorder—Propranolol—hypertension	6.6e-05	0.00138	CcSEcCtD
Drospirenone—Nausea—Prazosin—hypertension	6.58e-05	0.00137	CcSEcCtD
Drospirenone—Nausea—Bumetanide—hypertension	6.58e-05	0.00137	CcSEcCtD
Drospirenone—Mental disorder—Telmisartan—hypertension	6.55e-05	0.00137	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Eplerenone—hypertension	6.55e-05	0.00137	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Nifedipine—hypertension	6.5e-05	0.00136	CcSEcCtD
Drospirenone—Erythema multiforme—Furosemide—hypertension	6.49e-05	0.00135	CcSEcCtD
Drospirenone—Testolactone—CYP19A1—hypertension	6.46e-05	0.0337	CrCbGaD
Drospirenone—Nervous system disorder—Indapamide—hypertension	6.45e-05	0.00135	CcSEcCtD
Drospirenone—Nervous system disorder—Diltiazem—hypertension	6.45e-05	0.00135	CcSEcCtD
Drospirenone—Angiopathy—Perindopril—hypertension	6.41e-05	0.00134	CcSEcCtD
Drospirenone—Skin disorder—Indapamide—hypertension	6.39e-05	0.00133	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Guanabenz—hypertension	6.39e-05	0.00133	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Metoprolol—hypertension	6.39e-05	0.00133	CcSEcCtD
Drospirenone—Angiopathy—Irbesartan—hypertension	6.39e-05	0.00133	CcSEcCtD
Drospirenone—Skin disorder—Carvedilol—hypertension	6.33e-05	0.00132	CcSEcCtD
Drospirenone—Erythema multiforme—Losartan—hypertension	6.26e-05	0.00131	CcSEcCtD
Drospirenone—Skin disorder—Doxazosin—hypertension	6.26e-05	0.0013	CcSEcCtD
Drospirenone—Acute coronary syndrome—Ramipril—hypertension	6.24e-05	0.0013	CcSEcCtD
Drospirenone—Angiopathy—Furosemide—hypertension	6.23e-05	0.0013	CcSEcCtD
Drospirenone—Nausea—Bepridil—hypertension	6.22e-05	0.0013	CcSEcCtD
Drospirenone—Myocardial infarction—Ramipril—hypertension	6.2e-05	0.00129	CcSEcCtD
Drospirenone—Nervous system disorder—Eplerenone—hypertension	6.2e-05	0.00129	CcSEcCtD
Drospirenone—Mental disorder—Perindopril—hypertension	6.19e-05	0.00129	CcSEcCtD
Drospirenone—Depression—Timolol—hypertension	6.17e-05	0.00129	CcSEcCtD
Drospirenone—Angiopathy—Betaxolol—hypertension	6.17e-05	0.00129	CcSEcCtD
Drospirenone—Nervous system disorder—Nifedipine—hypertension	6.16e-05	0.00128	CcSEcCtD
Drospirenone—Nausea—Penbutolol—hypertension	6.15e-05	0.00128	CcSEcCtD
Drospirenone—Skin disorder—Eplerenone—hypertension	6.14e-05	0.00128	CcSEcCtD
Drospirenone—Skin disorder—Nifedipine—hypertension	6.1e-05	0.00127	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Valsartan—hypertension	6.03e-05	0.00126	CcSEcCtD
Drospirenone—Angiopathy—Losartan—hypertension	6.01e-05	0.00125	CcSEcCtD
Drospirenone—Nausea—Candesartan—hypertension	6e-05	0.00125	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Olmesartan—hypertension	6e-05	0.00125	CcSEcCtD
Drospirenone—Mental disorder—Betaxolol—hypertension	5.95e-05	0.00124	CcSEcCtD
Drospirenone—Nausea—Methyldopa—hypertension	5.92e-05	0.00123	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Propranolol—hypertension	5.87e-05	0.00122	CcSEcCtD
Drospirenone—Nausea—Hydralazine—hypertension	5.81e-05	0.00121	CcSEcCtD
Drospirenone—Nausea—Amiloride—hypertension	5.81e-05	0.00121	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Clonidine—hypertension	5.75e-05	0.0012	CcSEcCtD
Drospirenone—Nausea—Pindolol—hypertension	5.74e-05	0.0012	CcSEcCtD
Drospirenone—Depression—Lisinopril—hypertension	5.72e-05	0.00119	CcSEcCtD
Drospirenone—Nervous system disorder—Valsartan—hypertension	5.71e-05	0.00119	CcSEcCtD
Drospirenone—Nervous system disorder—Olmesartan—hypertension	5.68e-05	0.00118	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Indapamide—hypertension	5.68e-05	0.00118	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Diltiazem—hypertension	5.68e-05	0.00118	CcSEcCtD
Drospirenone—Acute coronary syndrome—Lisinopril—hypertension	5.66e-05	0.00118	CcSEcCtD
Drospirenone—Skin disorder—Valsartan—hypertension	5.65e-05	0.00118	CcSEcCtD
Drospirenone—Nausea—Quinapril—hypertension	5.64e-05	0.00118	CcSEcCtD
Drospirenone—Testosterone Propionate—COMT—hypertension	5.63e-05	0.0293	CrCbGaD
Drospirenone—Skin disorder—Olmesartan—hypertension	5.62e-05	0.00117	CcSEcCtD
Drospirenone—Myocardial infarction—Lisinopril—hypertension	5.62e-05	0.00117	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Carvedilol—hypertension	5.62e-05	0.00117	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Trandolapril—hypertension	5.6e-05	0.00117	CcSEcCtD
Drospirenone—Nausea—Benazepril—hypertension	5.55e-05	0.00116	CcSEcCtD
Drospirenone—Nausea—Nadolol—hypertension	5.53e-05	0.00115	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Telmisartan—hypertension	5.51e-05	0.00115	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Eplerenone—hypertension	5.46e-05	0.00114	CcSEcCtD
Drospirenone—Nausea—Isradipine—hypertension	5.44e-05	0.00114	CcSEcCtD
Drospirenone—Nervous system disorder—Clonidine—hypertension	5.44e-05	0.00113	CcSEcCtD
Drospirenone—Nausea—Guanfacine—hypertension	5.42e-05	0.00113	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Nifedipine—hypertension	5.42e-05	0.00113	CcSEcCtD
Drospirenone—Nausea—Nicardipine—hypertension	5.4e-05	0.00113	CcSEcCtD
Drospirenone—Skin disorder—Clonidine—hypertension	5.39e-05	0.00112	CcSEcCtD
Drospirenone—Erythema multiforme—Ramipril—hypertension	5.37e-05	0.00112	CcSEcCtD
Drospirenone—Nausea—Felodipine—hypertension	5.34e-05	0.00111	CcSEcCtD
Drospirenone—Nausea—Metolazone—hypertension	5.34e-05	0.00111	CcSEcCtD
Drospirenone—Nausea—Spironolactone—hypertension	5.33e-05	0.00111	CcSEcCtD
Drospirenone—Nervous system disorder—Trandolapril—hypertension	5.31e-05	0.00111	CcSEcCtD
Drospirenone—Skin disorder—Trandolapril—hypertension	5.25e-05	0.0011	CcSEcCtD
Drospirenone—Nausea—Esmolol—hypertension	5.22e-05	0.00109	CcSEcCtD
Drospirenone—Nervous system disorder—Telmisartan—hypertension	5.21e-05	0.00109	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Perindopril—hypertension	5.2e-05	0.00108	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—hypertension	5.18e-05	0.00108	CcSEcCtD
Drospirenone—Skin disorder—Telmisartan—hypertension	5.16e-05	0.00108	CcSEcCtD
Drospirenone—Nausea—Terazosin—hypertension	5.15e-05	0.00107	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Furosemide—hypertension	5.05e-05	0.00105	CcSEcCtD
Drospirenone—Angiopathy—Timolol—hypertension	5.04e-05	0.00105	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Valsartan—hypertension	5.02e-05	0.00105	CcSEcCtD
Drospirenone—Nausea—Acebutolol—hypertension	5.02e-05	0.00105	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—hypertension	5e-05	0.00104	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Olmesartan—hypertension	5e-05	0.00104	CcSEcCtD
Drospirenone—Mental disorder—Ramipril—hypertension	4.98e-05	0.00104	CcSEcCtD
Drospirenone—Nausea—Labetalol—hypertension	4.97e-05	0.00104	CcSEcCtD
Drospirenone—Nervous system disorder—Perindopril—hypertension	4.92e-05	0.00103	CcSEcCtD
Drospirenone—Nervous system disorder—Irbesartan—hypertension	4.9e-05	0.00102	CcSEcCtD
Drospirenone—Skin disorder—Perindopril—hypertension	4.87e-05	0.00102	CcSEcCtD
Drospirenone—Erythema multiforme—Lisinopril—hypertension	4.87e-05	0.00102	CcSEcCtD
Drospirenone—Mental disorder—Timolol—hypertension	4.86e-05	0.00101	CcSEcCtD
Drospirenone—Skin disorder—Irbesartan—hypertension	4.86e-05	0.00101	CcSEcCtD
Drospirenone—Nausea—Eprosartan—hypertension	4.82e-05	0.001	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Clonidine—hypertension	4.79e-05	0.000999	CcSEcCtD
Drospirenone—Nervous system disorder—Furosemide—hypertension	4.78e-05	0.000998	CcSEcCtD
Drospirenone—Skin disorder—Furosemide—hypertension	4.74e-05	0.000988	CcSEcCtD
Drospirenone—Eplerenone—CYP3A5—hypertension	4.74e-05	0.0247	CrCbGaD
Drospirenone—Nervous system disorder—Betaxolol—hypertension	4.74e-05	0.000988	CcSEcCtD
Drospirenone—Skin disorder—Betaxolol—hypertension	4.69e-05	0.000978	CcSEcCtD
Drospirenone—Nausea—Nisoldipine—hypertension	4.68e-05	0.000975	CcSEcCtD
Drospirenone—Nausea—Amlodipine—hypertension	4.68e-05	0.000975	CcSEcCtD
Drospirenone—Angiopathy—Lisinopril—hypertension	4.67e-05	0.000975	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Trandolapril—hypertension	4.67e-05	0.000974	CcSEcCtD
Drospirenone—Nervous system disorder—Losartan—hypertension	4.62e-05	0.000963	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Telmisartan—hypertension	4.59e-05	0.000957	CcSEcCtD
Drospirenone—Mental disorder—Lisinopril—hypertension	4.51e-05	0.000941	CcSEcCtD
Drospirenone—Nausea—Metoprolol—hypertension	4.4e-05	0.000917	CcSEcCtD
Drospirenone—Nausea—Guanabenz—hypertension	4.4e-05	0.000917	CcSEcCtD
Drospirenone—Medrysone—NR3C1—hypertension	4.39e-05	0.0229	CrCbGaD
Drospirenone—Gastrointestinal disorder—Perindopril—hypertension	4.33e-05	0.000903	CcSEcCtD
Drospirenone—Progesterone—NR3C2—hypertension	4.33e-05	0.0226	CrCbGaD
Drospirenone—Gastrointestinal disorder—Irbesartan—hypertension	4.32e-05	0.0009	CcSEcCtD
Drospirenone—Flurandrenolide—NR3C1—hypertension	4.23e-05	0.022	CrCbGaD
Drospirenone—Gastrointestinal disorder—Furosemide—hypertension	4.21e-05	0.000878	CcSEcCtD
Drospirenone—Testosterone Propionate—AR—hypertension	4.2e-05	0.0219	CrCbGaD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—hypertension	4.18e-05	0.000872	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Betaxolol—hypertension	4.17e-05	0.000869	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Timolol—hypertension	4.09e-05	0.000852	CcSEcCtD
Drospirenone—Nausea—Propranolol—hypertension	4.04e-05	0.000842	CcSEcCtD
Drospirenone—Cortisone acetate—NR3C1—hypertension	4.03e-05	0.021	CrCbGaD
Drospirenone—Nervous system disorder—Ramipril—hypertension	3.96e-05	0.000825	CcSEcCtD
Drospirenone—Skin disorder—Ramipril—hypertension	3.92e-05	0.000817	CcSEcCtD
Drospirenone—Nausea—Diltiazem—hypertension	3.91e-05	0.000815	CcSEcCtD
Drospirenone—Nausea—Indapamide—hypertension	3.91e-05	0.000815	CcSEcCtD
Drospirenone—Megestrol acetate—NR3C1—hypertension	3.88e-05	0.0202	CrCbGaD
Drospirenone—Nervous system disorder—Timolol—hypertension	3.87e-05	0.000807	CcSEcCtD
Drospirenone—Nausea—Carvedilol—hypertension	3.87e-05	0.000807	CcSEcCtD
Drospirenone—Skin disorder—Timolol—hypertension	3.83e-05	0.000799	CcSEcCtD
Drospirenone—Nausea—Doxazosin—hypertension	3.83e-05	0.000798	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	3.79e-05	0.000791	CcSEcCtD
Drospirenone—Nausea—Fosinopril—hypertension	3.78e-05	0.000788	CcSEcCtD
Drospirenone—Nausea—Eplerenone—hypertension	3.76e-05	0.000783	CcSEcCtD
Drospirenone—Nausea—Nifedipine—hypertension	3.73e-05	0.000778	CcSEcCtD
Drospirenone—Nausea—Verapamil—hypertension	3.71e-05	0.000774	CcSEcCtD
Drospirenone—Spironolactone—AR—hypertension	3.56e-05	0.0185	CrCbGaD
Drospirenone—Skin disorder—Lisinopril—hypertension	3.55e-05	0.000741	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Ramipril—hypertension	3.48e-05	0.000727	CcSEcCtD
Drospirenone—Nausea—Valsartan—hypertension	3.46e-05	0.000721	CcSEcCtD
Drospirenone—Nausea—Olmesartan—hypertension	3.44e-05	0.000717	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Timolol—hypertension	3.41e-05	0.00071	CcSEcCtD
Drospirenone—Medroxyprogesterone Acetate—AR—hypertension	3.34e-05	0.0174	CrCbGaD
Drospirenone—Nausea—Clonidine—hypertension	3.29e-05	0.000687	CcSEcCtD
Drospirenone—Nausea—Trandolapril—hypertension	3.21e-05	0.00067	CcSEcCtD
Drospirenone—Nausea—Enalapril—hypertension	3.2e-05	0.000667	CcSEcCtD
Drospirenone—Progesterone—CYP17A1—hypertension	3.17e-05	0.0165	CrCbGaD
Drospirenone—Gastrointestinal disorder—Lisinopril—hypertension	3.16e-05	0.000659	CcSEcCtD
Drospirenone—Nausea—Telmisartan—hypertension	3.16e-05	0.000658	CcSEcCtD
Drospirenone—Methyltestosterone—AR—hypertension	3.14e-05	0.0164	CrCbGaD
Drospirenone—Nausea—Captopril—hypertension	3.07e-05	0.00064	CcSEcCtD
Drospirenone—Norethindrone—CYP3A5—hypertension	3e-05	0.0156	CrCbGaD
Drospirenone—Nausea—Perindopril—hypertension	2.98e-05	0.000622	CcSEcCtD
Drospirenone—Nausea—Irbesartan—hypertension	2.97e-05	0.000619	CcSEcCtD
Drospirenone—Testosterone—CYP11A1—hypertension	2.95e-05	0.0154	CrCbGaD
Drospirenone—Nausea—Hydrochlorothiazide—hypertension	2.95e-05	0.000614	CcSEcCtD
Drospirenone—Nausea—Furosemide—hypertension	2.9e-05	0.000604	CcSEcCtD
Drospirenone—Progesterone—ABCC1—hypertension	2.87e-05	0.015	CrCbGaD
Drospirenone—Nausea—Betaxolol—hypertension	2.87e-05	0.000598	CcSEcCtD
Drospirenone—Nausea—Losartan—hypertension	2.8e-05	0.000583	CcSEcCtD
Drospirenone—Methyltestosterone—CYP19A1—hypertension	2.63e-05	0.0137	CrCbGaD
Drospirenone—Spironolactone—NR3C1—hypertension	2.41e-05	0.0126	CrCbGaD
Drospirenone—Nausea—Ramipril—hypertension	2.4e-05	0.0005	CcSEcCtD
Drospirenone—Nausea—Timolol—hypertension	2.34e-05	0.000489	CcSEcCtD
Drospirenone—Medroxyprogesterone Acetate—NR3C1—hypertension	2.26e-05	0.0118	CrCbGaD
Drospirenone—Nausea—Lisinopril—hypertension	2.17e-05	0.000453	CcSEcCtD
Drospirenone—Hydrocortisone—CYP3A5—hypertension	2.15e-05	0.0112	CrCbGaD
Drospirenone—Progesterone—AR—hypertension	1.93e-05	0.01	CrCbGaD
Drospirenone—Testosterone—AR—hypertension	1.82e-05	0.00949	CrCbGaD
Drospirenone—Progesterone—CYP3A5—hypertension	1.75e-05	0.00911	CrCbGaD
Drospirenone—Testosterone—CYP3A5—hypertension	1.65e-05	0.00862	CrCbGaD
Drospirenone—Hydrocortisone—NR3C1—hypertension	1.6e-05	0.00835	CrCbGaD
Drospirenone—Testosterone—CYP19A1—hypertension	1.52e-05	0.00794	CrCbGaD
Drospirenone—Progesterone—NR3C1—hypertension	1.31e-05	0.00681	CrCbGaD
Drospirenone—Progesterone—CYP1A1—hypertension	1.19e-05	0.00618	CrCbGaD
Drospirenone—Norethindrone—ALB—hypertension	1.13e-05	0.00591	CrCbGaD
Drospirenone—Testosterone—CYP1A1—hypertension	1.12e-05	0.00584	CrCbGaD
Drospirenone—Methyltestosterone—ALB—hypertension	1.08e-05	0.00561	CrCbGaD
Drospirenone—Testosterone—ALB—hypertension	6.24e-06	0.00325	CrCbGaD
Drospirenone—PTGS2—Metabolism—KCNJ11—hypertension	3.66e-06	0.000109	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—LPA—hypertension	3.66e-06	0.000109	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—HSD3B2—hypertension	3.66e-06	0.000109	CbGpPWpGaD
Drospirenone—AR—Gene Expression—PRKCD—hypertension	3.66e-06	0.000109	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PIK3R1—hypertension	3.63e-06	0.000108	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GNAS—hypertension	3.62e-06	0.000108	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ADRA2A—hypertension	3.61e-06	0.000108	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—POMC—hypertension	3.6e-06	0.000107	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—INS—hypertension	3.58e-06	0.000107	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NCF2—hypertension	3.56e-06	0.000106	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—MYC—hypertension	3.56e-06	0.000106	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—APOB—hypertension	3.55e-06	0.000106	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PTK2—hypertension	3.53e-06	0.000105	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CCL2—hypertension	3.52e-06	0.000105	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PPARA—hypertension	3.52e-06	0.000105	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—LRP2—hypertension	3.51e-06	0.000105	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP2C18—hypertension	3.51e-06	0.000105	CbGpPWpGaD
Drospirenone—AR—Gene Expression—PPARA—hypertension	3.51e-06	0.000104	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—EDN1—hypertension	3.49e-06	0.000104	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—IGF1—hypertension	3.46e-06	0.000103	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCL5—hypertension	3.46e-06	0.000103	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—MYC—hypertension	3.43e-06	0.000102	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—SERPINE1—hypertension	3.43e-06	0.000102	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—AGT—hypertension	3.41e-06	0.000102	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SLC9A1—hypertension	3.39e-06	0.000101	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—LPL—hypertension	3.39e-06	0.000101	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—HSPG2—hypertension	3.38e-06	0.000101	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—TH—hypertension	3.38e-06	0.000101	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CALM2—hypertension	3.36e-06	0.0001	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—H2AFX—hypertension	3.36e-06	0.0001	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—RPS6KB1—hypertension	3.36e-06	0.0001	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PDGFRB—hypertension	3.36e-06	0.0001	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—MMP2—hypertension	3.35e-06	9.99e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—APOE—hypertension	3.34e-06	9.95e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PTGS2—hypertension	3.32e-06	9.91e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ADCY5—hypertension	3.32e-06	9.88e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TGFBR1—hypertension	3.31e-06	9.87e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—CAV1—hypertension	3.31e-06	9.86e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—APOA1—hypertension	3.3e-06	9.84e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PRKCG—hypertension	3.29e-06	9.82e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GCG—hypertension	3.28e-06	9.79e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—SLC2A4—hypertension	3.28e-06	9.79e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ITGB3—hypertension	3.27e-06	9.75e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PRKCA—hypertension	3.27e-06	9.75e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ALOX5—hypertension	3.26e-06	9.72e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GLP1R—hypertension	3.26e-06	9.72e-05	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hypertension	3.26e-06	9.72e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—YWHAZ—hypertension	3.24e-06	9.67e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SPP1—hypertension	3.21e-06	9.56e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NGF—hypertension	3.21e-06	9.56e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NCF1—hypertension	3.21e-06	9.56e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GOT1—hypertension	3.18e-06	9.48e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ENO1—hypertension	3.18e-06	9.46e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PRKCD—hypertension	3.12e-06	9.3e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCR5—hypertension	3.12e-06	9.3e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—STK11—hypertension	3.09e-06	9.21e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP19A1—hypertension	3.09e-06	9.21e-05	CbGpPWpGaD
Drospirenone—AR—Gene Expression—NOTCH1—hypertension	3.07e-06	9.15e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HTR2A—hypertension	3.05e-06	9.1e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—C3—hypertension	3.05e-06	9.09e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—GOT2—hypertension	3.03e-06	9.03e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CYBA—hypertension	3.02e-06	8.99e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ALDH2—hypertension	2.98e-06	8.89e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PDGFB—hypertension	2.97e-06	8.85e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FGFR1—hypertension	2.95e-06	8.8e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CALCA—hypertension	2.92e-06	8.69e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—hypertension	2.91e-06	8.67e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HIF1A—hypertension	2.91e-06	8.67e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—HBA1—hypertension	2.91e-06	8.67e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PTEN—hypertension	2.9e-06	8.64e-05	CbGpPWpGaD
Drospirenone—AR—Gene Expression—PPARG—hypertension	2.9e-06	8.64e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AGT—hypertension	2.9e-06	8.64e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP11A1—hypertension	2.89e-06	8.61e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—COMT—hypertension	2.87e-06	8.56e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—POMC—hypertension	2.87e-06	8.55e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CALM1—hypertension	2.85e-06	8.49e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—LEP—hypertension	2.84e-06	8.46e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—APOE—hypertension	2.84e-06	8.46e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GSTT1—hypertension	2.84e-06	8.46e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SLC9A1—hypertension	2.84e-06	8.46e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PPARGC1A—hypertension	2.83e-06	8.44e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GNB3—hypertension	2.83e-06	8.44e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—HMOX1—hypertension	2.82e-06	8.4e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ADRBK1—hypertension	2.82e-06	8.39e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CAV1—hypertension	2.81e-06	8.38e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—APOA1—hypertension	2.81e-06	8.36e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GCLC—hypertension	2.81e-06	8.36e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CETP—hypertension	2.81e-06	8.36e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CXCL8—hypertension	2.79e-06	8.3e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—KDR—hypertension	2.78e-06	8.29e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CAT—hypertension	2.78e-06	8.29e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NOS1—hypertension	2.78e-06	8.27e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CALM2—hypertension	2.77e-06	8.24e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—EP300—hypertension	2.76e-06	8.24e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GNAS—hypertension	2.76e-06	8.22e-05	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—hypertension	2.75e-06	8.21e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SLC2A4—hypertension	2.7e-06	8.05e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—APOB—hypertension	2.7e-06	8.05e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP17A1—hypertension	2.69e-06	8.01e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PRKCB—hypertension	2.68e-06	7.98e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FN1—hypertension	2.68e-06	7.98e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—F2—hypertension	2.68e-06	7.98e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ENO1—hypertension	2.66e-06	7.93e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PTGS1—hypertension	2.66e-06	7.93e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—KL—hypertension	2.65e-06	7.89e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GSTM1—hypertension	2.63e-06	7.83e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NOTCH1—hypertension	2.62e-06	7.81e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—ALB—hypertension	2.62e-06	7.8e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—GOT1—hypertension	2.61e-06	7.79e-05	CbGpPWpGaD
Drospirenone—AR—Gene Expression—SERPINE1—hypertension	2.61e-06	7.78e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—LPL—hypertension	2.58e-06	7.68e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PRL—hypertension	2.58e-06	7.68e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CTGF—hypertension	2.56e-06	7.63e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HDAC1—hypertension	2.54e-06	7.57e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GOT2—hypertension	2.54e-06	7.56e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—HMGCR—hypertension	2.54e-06	7.56e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ADCY5—hypertension	2.52e-06	7.52e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GPX1—hypertension	2.51e-06	7.5e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—hypertension	2.5e-06	7.46e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PRKCA—hypertension	2.49e-06	7.42e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP1A1—hypertension	2.49e-06	7.42e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ADRA2A—hypertension	2.48e-06	7.4e-05	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—AKT1—hypertension	2.47e-06	7.36e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CD36—hypertension	2.45e-06	7.3e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—POMC—hypertension	2.44e-06	7.27e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—INS—hypertension	2.43e-06	7.23e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PRKCE—hypertension	2.41e-06	7.19e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCL2—hypertension	2.39e-06	7.11e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PDGFA—hypertension	2.38e-06	7.1e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TGFBR2—hypertension	2.35e-06	7e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IGF1—hypertension	2.35e-06	6.99e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AKT2—hypertension	2.34e-06	6.99e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—TH—hypertension	2.32e-06	6.93e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—MTHFR—hypertension	2.32e-06	6.92e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CALM2—hypertension	2.32e-06	6.9e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PPARA—hypertension	2.28e-06	6.79e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SLC2A4—hypertension	2.26e-06	6.74e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GCG—hypertension	2.26e-06	6.74e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SERPINE1—hypertension	2.23e-06	6.64e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—APOB—hypertension	2.22e-06	6.61e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—AGT—hypertension	2.21e-06	6.57e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GOT1—hypertension	2.19e-06	6.53e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CALM1—hypertension	2.17e-06	6.46e-05	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—MYC—hypertension	2.17e-06	6.46e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—APOE—hypertension	2.16e-06	6.44e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FGF2—hypertension	2.16e-06	6.43e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—RHOA—hypertension	2.15e-06	6.41e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CAV1—hypertension	2.14e-06	6.38e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—APOA1—hypertension	2.14e-06	6.37e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NOS3—hypertension	2.13e-06	6.34e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PIK3R1—hypertension	2.13e-06	6.34e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP19A1—hypertension	2.13e-06	6.34e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—STK11—hypertension	2.13e-06	6.34e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—LPL—hypertension	2.12e-06	6.31e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—H2AFX—hypertension	2.1e-06	6.27e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PDGFRB—hypertension	2.1e-06	6.26e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ADCY5—hypertension	2.07e-06	6.18e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PRKCG—hypertension	2.06e-06	6.14e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PRKCA—hypertension	2.05e-06	6.1e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—YWHAZ—hypertension	2.03e-06	6.05e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—RELA—hypertension	2e-06	5.97e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hypertension	2e-06	5.95e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—COMT—hypertension	1.98e-06	5.89e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MTOR—hypertension	1.96e-06	5.85e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CCR5—hypertension	1.95e-06	5.82e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PRKCD—hypertension	1.95e-06	5.82e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PPARGC1A—hypertension	1.95e-06	5.81e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GNB3—hypertension	1.95e-06	5.81e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—HMOX1—hypertension	1.94e-06	5.78e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CAT—hypertension	1.91e-06	5.71e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MTHFR—hypertension	1.91e-06	5.69e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—EP300—hypertension	1.9e-06	5.67e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GNAS—hypertension	1.9e-06	5.66e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CXCL8—hypertension	1.89e-06	5.62e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PPARG—hypertension	1.88e-06	5.61e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—APOB—hypertension	1.86e-06	5.54e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PDGFB—hypertension	1.86e-06	5.53e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—POMC—hypertension	1.86e-06	5.53e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FGFR1—hypertension	1.85e-06	5.51e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—INS—hypertension	1.85e-06	5.5e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HIF1A—hypertension	1.82e-06	5.42e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GSTM1—hypertension	1.81e-06	5.39e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CALM1—hypertension	1.78e-06	5.31e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—APOE—hypertension	1.78e-06	5.29e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—LPL—hypertension	1.77e-06	5.29e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CAV1—hypertension	1.76e-06	5.24e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—APOA1—hypertension	1.76e-06	5.23e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ADCY5—hypertension	1.74e-06	5.18e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GPX1—hypertension	1.73e-06	5.16e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PRKCA—hypertension	1.71e-06	5.11e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP1A1—hypertension	1.71e-06	5.11e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MMP9—hypertension	1.71e-06	5.09e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CDKN1A—hypertension	1.7e-06	5.07e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PTEN—hypertension	1.7e-06	5.06e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ALB—hypertension	1.69e-06	5.04e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CD36—hypertension	1.69e-06	5.02e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MAPK8—hypertension	1.66e-06	4.95e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NOS2—hypertension	1.65e-06	4.93e-05	CbGpPWpGaD
Drospirenone—AR—Gene Expression—MYC—hypertension	1.65e-06	4.92e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NOTCH1—hypertension	1.64e-06	4.89e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PIK3R1—hypertension	1.62e-06	4.83e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—NOS3—hypertension	1.62e-06	4.83e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—EP300—hypertension	1.62e-06	4.82e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—MTHFR—hypertension	1.6e-06	4.76e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SRC—hypertension	1.57e-06	4.69e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PPARA—hypertension	1.57e-06	4.67e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—VEGFA—hypertension	1.53e-06	4.57e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—AGT—hypertension	1.52e-06	4.52e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—INS—hypertension	1.52e-06	4.52e-05	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—AKT1—hypertension	1.5e-06	4.48e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CALM1—hypertension	1.49e-06	4.45e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—APOE—hypertension	1.49e-06	4.43e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PTGS2—hypertension	1.48e-06	4.41e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CAV1—hypertension	1.47e-06	4.39e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—APOA1—hypertension	1.47e-06	4.38e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—AKT2—hypertension	1.47e-06	4.37e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MYC—hypertension	1.41e-06	4.2e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TGFB1—hypertension	1.41e-06	4.19e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SERPINE1—hypertension	1.39e-06	4.15e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—EGFR—hypertension	1.38e-06	4.11e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FGF2—hypertension	1.35e-06	4.02e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—RHOA—hypertension	1.34e-06	4.01e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NOS3—hypertension	1.33e-06	3.97e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PIK3R1—hypertension	1.33e-06	3.97e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PPARG—hypertension	1.3e-06	3.86e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PTEN—hypertension	1.29e-06	3.85e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—POMC—hypertension	1.28e-06	3.81e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—INS—hypertension	1.27e-06	3.79e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—EP300—hypertension	1.23e-06	3.67e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MTOR—hypertension	1.23e-06	3.66e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ALB—hypertension	1.16e-06	3.47e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TP53—hypertension	1.16e-06	3.45e-05	CbGpPWpGaD
Drospirenone—AR—Gene Expression—AKT1—hypertension	1.15e-06	3.41e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NOS3—hypertension	1.11e-06	3.32e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PIK3R1—hypertension	1.11e-06	3.32e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CDKN1A—hypertension	1.06e-06	3.17e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PTEN—hypertension	1.06e-06	3.16e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL6—hypertension	1.06e-06	3.16e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—EP300—hypertension	1.01e-06	3.02e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SRC—hypertension	9.84e-07	2.93e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AKT1—hypertension	9.78e-07	2.91e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PTEN—hypertension	8.89e-07	2.65e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MYC—hypertension	8.82e-07	2.63e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TGFB1—hypertension	8.8e-07	2.62e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—EGFR—hypertension	8.63e-07	2.57e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—EP300—hypertension	8.48e-07	2.53e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—AKT1—hypertension	7.44e-07	2.22e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—IL6—hypertension	6.63e-07	1.98e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—AKT1—hypertension	6.12e-07	1.82e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—AKT1—hypertension	5.12e-07	1.53e-05	CbGpPWpGaD
